Dr. Eric Kropp Inaugurated as 190th President of the New Hampshire Medical Society

Eric A. Kropp, MD, was inaugurated as the 190th president of the New Hampshire Medical Society during its 2021 Annual Scientific Conference held at the Omni Mount Washington Resort in Bretton Woods, succeeding anesthesiologist Dr. Kenton Allen.

In 2016, Dr. Kropp started his solo practice, Active Choice Healthcare, in Concord as a pioneer in Direct Primary Care and fostered New Hampshire law about this innovative and emerging medical practice model. He is a founding member of both the New England and National Direct Primary Care Alliances.

Read More

COVID-19 Pandemic, Update # 45 SARS-CoV-2 Monoclonal Antibody Therapy Updates Resumption of Healthcare Provider & Public Health Partner Webinars

On September 17, 2021, NH DHHS issued a health alert on SARS-CoV-2 monoclonal antibody therapy updates.

NH DPHS Health AlertsKey Points and Recommendations:

  • Management of patients with COVID-19 vary by setting and severity of illness; providers should familiarize themselves with COVID-19 treatment guidelines from both the National Institutes of Health (NIH) and the Infectious Disease Society of America (IDSA) 
    • Note the NIH has updated their guidance on use of bamlanivimab plus etesevimab but this not yet been incorporated into their guidance summary 
    • Review the recent CDC HAN advising against the use of ivermectin, which has not been shown to be effective at treating or preventing COVID-19 
Read More

Recall of LeadCare® Blood Lead Tests Due to Risk of Falsely Low Results, Update #1: Expanded Recall to Include all LeadCare® II Testing Supply Kits

On August 31, 2021, NH DHHS issued a health alert update on the recall of LeadCare blood lead tests.

Key Points and Recommendations:

  • Magellan Diagnostics, Inc. has expanded their product recall involving the LeadCare ® blood test kits. This expanded COOR-LO recall includes LeadCare® II Blood Test Kits lots: 2012M (Sublots -08, -09, -10, -11, -12, -13, and -14); 2018M; 2102M; 2109M, 2110M; 2111M; 2112M; 2113M; 2114M; and 2115M and is outlined below. These lots are in addition to previously recalled lots.
Read More

Coronavirus Disease 2019 (COVID-19) Outbreak, Update # 44 mRNA COVID-19 Vaccine 3rd Dose Recommendations

On August 13, 2021, NH DHHS issued a health alert on mRNA COVID-19 vaccine 3rd dose recommendations.

NH DPHS Health AlertsKey Points and Recommendations:

  • On August 12th, the U.S. Food and Drug Administration (FDA) authorized use of a 3rd dose of the Pfizer-BioNTech and Moderna COVID-19 vaccines for certain immunocompromised persons. The Emergency Use Authorization (EUA) amendment does NOT apply to the Janssen COVID-19 vaccine, or to individuals who received the Janssen vaccine as a primary series. 
Read More